Mitigating preterm encephalopathy continues to be one of the greatest challenges in
perinatal medicine. Preterm encephalopathy is associated with high mortality, serious …

Mitigating preterm encephalopathy continues to be one of the greatest challenges in
perinatal medicine. Preterm encephalopathy is associated with high mortality, serious …

There is an important unmet need to improve long term outcomes of encephalopathy for
preterm and term infants. Meta-analyses of large controlled trials suggest that maternal …

There is an important unmet need to further improve the outcome of neonatal
encephalopathy in term infants. Meta-analyses of large controlled trials now suggest that …

Magnesium sulphate (MgSO4) given to women in preterm labor reduces cerebral palsy in
their offspring but the mechanism behind this protection is unclear, limiting its effective, safe …

Objectives: The study aimed to evaluate the impact of antenatal exposure of magnesium
sulfate (MgSO4) on short-and long-term outcomes in preterm neonates born less than 32 …

The aim of this literature review is to determine if prenatal administration of magnesium
sulphate (MgSO4) provides neuroprotection in preterm infants. Data was analysed from five …

Objective To evaluate whether magnesium sulphate (MgSO4) given to women at risk of very‐
preterm birth would be neuroprotective in preterm newborns and would prevent neonatal …

Objective Antenatal magnesium sulfate (MgSO 4) treatment is associated with reduced risk
of cerebral palsy in preterm infants. We aimed to investigate whether this treatment leads to …

Background: The underlying neuro-protective mechanisms of antenatal magnesium sulfate
(MgSO 4) in infants born preterm remain poorly understood. Early neonatal brain injury may …